Izinova is being discontinued at the end December 2017 due to problems with a third-party manufacturer. Therapeutic alternatives remain available. Daklinza (daclatasvir) 90mg tablets (BMS): BMS is discontinuing Daklinza (daclatasvir) 90mg tablets from the EU market in December 2017 as part of a portfolio rationalisation process. The company has confirmed that the 30mg & 60mg presentations will remain available. Daklinza is indicated for the treatment of chronic HepatitisC and the recommended dose is 60mg (alternate dosage regimens can be managed by the remaining strengths). Fosamax (alendronic acid) 10mg tablets (MSD): MSD plans to discontinue Fosamax (alendronic acid) 10mg tablets with immediate effect from the UK market as part of a portfolio rationalisation process. Fosamax Once Weekly and generic alendronic acid 10mg tablets remain available. Nizatidine 150mg capsules (Flynn): Flynn plans to discontinue Nizatidine 150mg capsules with immediate effect from the UK market. Generic Nizatidine 150mg capsules remain available from other suppliers. Chlordiazepoxide tablets: Dr Reddy’s, the sole supplier of chlordiazepoxide tablets has discontinued this product in both the 5mg and 10mg strengths. Supplies of generic chlordiazepoxide capsules in 5mg and 10mg strengths are available from Crescent, Athlone and Kent. Supplies of the brand Librium are also available from Mylan.
Izinova is being discontinued at the end December 2017 due to problems with a third-party manufacturer. Therapeutic alternatives remain available. Daklinza (daclatasvir) 90mg tablets (BMS): BMS is discontinuing Daklinza (daclatasvir) 90mg tablets from the EU market in December 2017 as part of a portfolio rationalisation process. The company has confirmed that the 30mg & 60mg presentations will remain available. Daklinza is indicated for the treatment of chronic HepatitisC and the recommended dose is 60mg (alternate dosage regimens can be managed by the remaining strengths). Fosamax (alendronic acid) 10mg tablets (MSD): MSD plans to discontinue Fosamax (alendronic acid) 10mg tablets with immediate effect from the UK market as part of a portfolio rationalisation process. Fosamax Once Weekly and generic alendronic acid 10mg tablets remain available. Nizatidine 150mg capsules (Flynn): Flynn plans to discontinue Nizatidine 150mg capsules with immediate effect from the UK market. Generic Nizatidine 150mg capsules remain available from other suppliers. Chlordiazepoxide tablets: Dr Reddy’s, the sole supplier of chlordiazepoxide tablets has discontinued this product in both the 5mg and 10mg strengths. Supplies of generic chlordiazepoxide capsules in 5mg and 10mg strengths are available from Crescent, Athlone and Kent. Supplies of the brand Librium are also available from Mylan.
Supply-issues-update-for-primary-care-March-2018.docx